Versius-assisted inguinal hernia repair
Official title: Prospective Clinical Study to Evaluate the Safety and Efficacy of Versius in Robot-Assisted Inguinal Hernia Repair Surgery
Run by CMR Surgical Ltd · NCT07316517 · Data updated 2026-11-12
This trial tests the Versius robotic system to see if it can safely and effectively help adults have minimally invasive inguinal hernia repair.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | CMR Surgical Ltd Industry-sponsored |
| Locations | 2 sites (Milan and 1 other locations) |
| Status | Recruiting |
| Started | July 22, 2026 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | September 28, 2026 |
| Trial ID | NCT07316517 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 22 years and older planned for elective minimally invasive inguinal hernia repair who consent to participate.
✕Probably not a fit
Patients who do not benefit may include those with contraindications to general anesthesia, ASA IV or higher, active comorbidities preventing MIS, or contraindications to the Versius system.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates the Versius Surgical System for robotic-assisted inguinal hernia repair. Eligible adults undergoing elective minimally invasive repair are treated with the Versius system, and outcomes related to safety and efficacy are collected. The study excludes those unable to consent, with contraindications to general anesthesia or MIS surgery, ASA IV or higher, concurrent procedures, or contraindications to Versius use. Primary results focus on feasibility, safety events, and short-term surgical performance in participating centers. Locations include Milan and Barcelona in collaboration with two hospitals.
Why it matters
Potential benefit: If successful, patients could benefit from a safer or more accurate robotic-assisted repair with potentially shorter recovery.
How similar studies have gone: Robotic-assisted hernia repair trials have shown safety and feasibility in prior studies; this trial builds on that experience with the Versius platform.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult patients 22 years of age and older, deemed eligible for elective minimal invasive inguinal Hernia repair surgery. 2. Patients providing written informed consent to participate in the study. Exclusion Criteria: 1. Patient unwilling to provide informed consent. 2. Medical contraindication for general anaesthesia or minimally invasive procedure. 3. Patient participation in an interventional clinical study that could impact primary outcomes results. 4. Patient who falls into American Society of Anaesthesiologists (ASA) Class IV or above. 5. Patients undergoing a concomitant surgical procedure. 6. Contraindication for undergoing surgery with Versius (bleeding diathesis, active pregnancy or BMI ≥40 kg/m2).
Where it's running
-
Division of General Oncologic and Minimally Invasive Surgery, Niguarda Hospital Milan
Milan, Italy Recruiting -
Bellvitge University Hospital
Barcelona, Spain Not yet recruiting
Study contacts
- Principal investigator: Bruno Domenico Antonio Alampi, MD — Division of General Oncologic and Minimally Invasive Surgery, Niguarda Hospital Milan
- Study coordinator: Mark Slack, MD
- Email: mark.slack@cmrsurgical.com
- Phone: +44 7766 024389
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Versius Robotic Surgery in the NHS for soft-tissue procedures
This study tests how Versius robotic-assisted surgery compares to standard surgical methods for soft-tissue procedures in routine NHS care.
-
Versius robotic gallbladder removal: how well it works in adults
This study tests whether the Versius robotic system can safely and effectively perform gallbladder removal in adults without needing to switch to another method.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.